These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1224 related articles for article (PubMed ID: 36424614)

  • 41. ScRNA-seq and bulk RNA-seq reveal the characteristics of ferroptosis and establish a risk signature in cholangiocarcinoma.
    Yao W; Liu X; He Y; Tian M; Lu S; Wang Q; Zheng Y; Lv Z; Hao C; Xue D; Meng X
    Mol Ther Oncolytics; 2022 Dec; 27():48-60. PubMed ID: 36284715
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Identification of an Autophagy-Related Signature for Prognosis and Immunotherapy Response Prediction in Ovarian Cancer.
    Ding J; Wang C; Sun Y; Guo J; Liu S; Cheng Z
    Biomolecules; 2023 Feb; 13(2):. PubMed ID: 36830707
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A senescence-based prognostic gene signature for colorectal cancer and identification of the role of SPP1-positive macrophages in tumor senescence.
    Yu S; Chen M; Xu L; Mao E; Sun S
    Front Immunol; 2023; 14():1175490. PubMed ID: 37090726
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Ovarian cancer-specific dysregulated genes with prognostic significance: scRNA-Seq with bulk RNA-Seq data and experimental validation.
    Liu C; Zhang Y; Li X; Wang D
    Ann N Y Acad Sci; 2022 Jun; 1512(1):154-173. PubMed ID: 35247207
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Integrating single-cell and bulk RNA sequencing data unveils antigen presentation and process-related CAFS and establishes a predictive signature in prostate cancer.
    Wang W; Li T; Xie Z; Zhao J; Zhang Y; Ruan Y; Han B
    J Transl Med; 2024 Jan; 22(1):57. PubMed ID: 38221616
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Identification of a G-protein coupled receptor-related gene signature through bioinformatics analysis to construct a risk model for ovarian cancer prognosis.
    Ma S; Li R; Li G; Wei M; Li B; Li Y; Ha C
    Comput Biol Med; 2024 Aug; 178():108747. PubMed ID: 38897150
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Construction of Ovarian Cancer Prognostic Model Based on the Investigation of Ferroptosis-Related lncRNA.
    Yang S; Ji J; Wang M; Nie J; Wang S
    Biomolecules; 2023 Feb; 13(2):. PubMed ID: 36830675
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A fibroblast-associated signature predicts prognosis and immunotherapy in esophageal squamous cell cancer.
    Ren Q; Zhang P; Zhang X; Feng Y; Li L; Lin H; Yu Y
    Front Immunol; 2023; 14():1199040. PubMed ID: 37313409
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Characterization of tumor endothelial cells (TEC) in gastric cancer and development of a TEC-based risk signature using single-cell RNA-seq and bulk RNA-seq data.
    Fan M; Xu X; Hu Y
    Aging (Albany NY); 2024 Jun; 16(12):10252-10270. PubMed ID: 38870270
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Identification of a differentiation-related prognostic nomogram based on single-cell RNA sequencing in clear cell renal cell carcinoma.
    Xia ZN; Wu JG; Yao WH; Meng YY; Jian WG; Wang TD; Xue W; Yu YP; Cai LC; Wang XY; Zhang P; Li ZY; Zhou H; Jiang ZC; Zhou JY; Zhang C
    Sci Rep; 2022 Jun; 12(1):10973. PubMed ID: 35768519
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Immunogenic cell death-related gene landscape predicts the overall survival and immune infiltration status of ovarian cancer.
    Zhang W; Liu T; Jiang L; Chen J; Li Q; Wang J
    Front Genet; 2022; 13():1001239. PubMed ID: 36425071
    [No Abstract]   [Full Text] [Related]  

  • 52. Establishment and validation of an aging-related risk signature associated with prognosis and tumor immune microenvironment in breast cancer.
    Wang Z; Liu H; Gong Y; Cheng Y
    Eur J Med Res; 2022 Dec; 27(1):317. PubMed ID: 36581948
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Integrating Single-Cell RNA-Seq and Bulk RNA-Seq to Construct a Novel γδT Cell-Related Prognostic Signature for Human Papillomavirus-Infected Cervical Cancer.
    Wang X; Jin Y; Xu L; Tao S; Wu Y; Ao C
    Cancer Control; 2024; 31():10732748241274228. PubMed ID: 39206965
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Identification and validation of a seven-gene prognostic marker in colon cancer based on single-cell transcriptome analysis.
    Zhou Y; Guo Y; Wang Y
    IET Syst Biol; 2022 Apr; 16(2):72-83. PubMed ID: 35352485
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Single-cell RNA sequencing reveals that MYBL2 in malignant epithelial cells is involved in the development and progression of ovarian cancer.
    Shao W; Lin Z; Xiahou Z; Zhao F; Xu J; Liu X; Cai P
    Front Immunol; 2024; 15():1438198. PubMed ID: 39136009
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Integrated Analysis Construct a Tumor-Associated Macrophage Novel Signature with Promising Implications in Predicting the Prognosis and Immunotherapeutic Response of Gastric Cancer Patients.
    Xin H; Chen Y; Niu H; Li X; Gai X; Cui G
    Dig Dis Sci; 2024 Jun; 69(6):2055-2073. PubMed ID: 38573378
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Identification and Validation of NK Marker Genes in Ovarian Cancer by scRNA-seq Combined with WGCNA Algorithm.
    He X; Feng W
    Mediators Inflamm; 2023; 2023():6845701. PubMed ID: 37144238
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Exosome-Associated Gene Signature for Predicting the Prognosis of Ovarian Cancer Patients.
    Zhu Z; Geng R; Zhang Y; Liu J; Bai J
    J Immunol Res; 2023; 2023():8727884. PubMed ID: 36726489
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Development of a Cancer-Associated Fibroblast-Related Prognostic Model in Breast Cancer via Bulk and Single-Cell RNA Sequencing.
    Hu J; Jiang Y; Wei Q; Li B; Xu S; Wei G; Li P; Chen W; Lv W; Xiao X; Lu Y; Huang X
    Biomed Res Int; 2022; 2022():2955359. PubMed ID: 36510567
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Identification of Novel Anoikis-Related Gene Signatures to Predict the Prognosis, Immune Microenvironment, and Drug Sensitivity of Breast Cancer Patients.
    Liu J; Wu H; Wang Q; Jin S; Hou S; Shen Z; Zhao L; Xu S; Pang D
    Cancer Control; 2024; 31():10732748241288118. PubMed ID: 39340434
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 62.